TRASTUZUMAB EMTANSINE

Clinical trials for TRASTUZUMAB EMTANSINE explained in plain language.

Never miss a new study

Get alerted when new TRASTUZUMAB EMTANSINE trials appear

Sign up with your email to follow new studies for TRASTUZUMAB EMTANSINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can switching breast cancer drugs buy more time? new study aims to find out.

Knowledge-focused Recruiting now

This study is for people with advanced HER2-positive breast cancer whose current treatment (trastuzumab deruxtecan) has stopped working. Researchers want to see if switching immediately to another targeted drug (trastuzumab emtansine) can help control the cancer longer. About 100…

Matched conditions: TRASTUZUMAB EMTANSINE

Sponsor: Seoul National University Hospital • Aim: Knowledge-focused

Last updated May 06, 2026 16:00 UTC

TRASTUZUMAB EMTANSINE

Get alerted when new TRASTUZUMAB EMTANSINE trials appear

Can switching breast cancer drugs buy more time? new study aims to find out.